0001213900-21-014908.txt : 20210311
0001213900-21-014908.hdr.sgml : 20210311
20210311173646
ACCESSION NUMBER: 0001213900-21-014908
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210309
FILED AS OF DATE: 20210311
DATE AS OF CHANGE: 20210311
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Danenberg Noam
CENTRAL INDEX KEY: 0001720898
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-52545
FILM NUMBER: 21734437
MAIL ADDRESS:
STREET 1: 4 BOROCHOV ST
CITY: HOD HASHARON
STATE: L3
ZIP: 4520404
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Wize Pharma, Inc.
CENTRAL INDEX KEY: 0001218683
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 880445167
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 24 HANAGAR ST
CITY: HOD HASHARON
STATE: L3
ZIP: 4527713
BUSINESS PHONE: 972 472 260 0536
MAIL ADDRESS:
STREET 1: 24 HANAGAR ST
CITY: HOD HASHARON
STATE: L3
ZIP: 4527713
FORMER COMPANY:
FORMER CONFORMED NAME: OphthaliX, Inc.
DATE OF NAME CHANGE: 20120207
FORMER COMPANY:
FORMER CONFORMED NAME: DENALI CONCRETE MANAGEMENT INC
DATE OF NAME CHANGE: 20030213
4
1
ownership.xml
X0306
4
2021-03-09
1
0001218683
Wize Pharma, Inc.
WIZP
0001720898
Danenberg Noam
C/O WIZE PHARMA, INC.
24 HANAGAR STREET
HOD HASHARON
L3
4527708
ISRAEL
1
1
0
0
Chief Executive Officer
Common Stock, par value $0.001 per share
2021-03-09
4
P
0
2916667
0.12
A
3165705
D
The Reporting Person resigned as Chief Executive Officer effective as of March 9, 2021.
/s/ Noam Dannenberg
2021-03-11